Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;57(2):162-7.
doi: 10.1373/clinchem.2010.148833. Epub 2010 Nov 22.

Therapeutic approaches to target inflammation in type 2 diabetes

Affiliations
Review

Therapeutic approaches to target inflammation in type 2 diabetes

Allison B Goldfine et al. Clin Chem. 2011 Feb.

Abstract

Background: Chronic inflammation may participate in the pathogenesis of insulin resistance, type 2 diabetes, and cardiovascular disease and may be a common denominator that links obesity to these disease states.

Content: Epidemiologic studies have linked inflammatory biomarkers to incident diabetes and cardiovascular disease risk. Cellular and animal studies have provided support to the idea that inflammation mediates these disease processes, providing impetus to pharmacologically target these pathways for disease treatment and prevention. We review clinical strategies to target inflammation, with a focus on the antiinflammatory and antihyperglycemic effects of salicylates.

Summary: The evolving concept of diet-induced obesity driving insulin resistance, type 2 diabetes, and cardiovascular disease through immunologic processes provides new opportunities for the use of antiinflammatory strategies to correct the metabolic consequences of excess adiposity.

PubMed Disclaimer

Conflict of interest statement

Authors’ Disclosures or Potential Conflicts of Interest: Upon manuscript submission, all authors completed the Disclosures of Potential Conflict of Interest form. Potential conflicts of interest:

Employment or Leadership: V. Fonseca, NIH, TINSAL-T2D Trial Steering Committee; A. Goldfine, NIH, TINSAL-T2D Trial Steering Committee and NIH, TINSAL-CVD Trial Steering Committee; S. Shoelson, NIH, TINSAL-T2D Trial Steering Committee and NIH, TINSAL-CVD Trial Steering Committee.

Consultant or Advisory Role: V. Fonseca, Xoma; S.E. Shoelson, Catabasis, Metabolex, Kowa, and Syndexa.

Stock Ownership: None declared.

Honoraria: V. Fonseca, Xoma; S.E. Shoelson, Merck.

Expert Testimony: None declared.

Figures

Fig. 1
Fig. 1. Adipocyte cell size and adipose tissue cellular content vary with diet-induced obesity
(Left), Adipose tissue from C57BL/6J mice fed regular chow; infiltrating inflammatory cells are not evident. (Right), Adipose tissue from age- and sex-matched, genetically identical mice fed a diet high in fat. On average, adipocytes are larger, and infiltrating inflammatory cells are readily apparent.

References

    1. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51:455–61. - PubMed
    1. Rana JS, Boekholdt SM, Ridker PM, Jukema JW, Luben R, Bingham SA, et al. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC- Norfolk Prospective Population Study. J Intern Med. 2007;262:678–89. - PubMed
    1. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–34. - PubMed
    1. Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M, Koenig W. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984–1998. Arch Intern Med. 2003;163:93–9. - PubMed
    1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–9. - PubMed

Publication types

MeSH terms

Substances